Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.

Regina Miftakhova; Tove Sandberg; Sharon Longno; Peter Björk; Sven Björnsson; Vladimir L J Lazarevic; Jenny  Persson; Anders Bredberg

doi:10.1016/j.leukres.2009.12.001

Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.

Regina Miftakhova, Tove Sandberg, Sharon Longno, Peter Björk, Sven Björnsson, Vladimir L J Lazarevic, Jenny Persson, Anders Bredberg

Malmö universitet

Forskningsoutput: Tidskriftsbidrag › Letter

Originalspråk	engelska
Sidor (från-till)	E145-E149
Tidskrift	Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis
Volym	34
DOI	https://doi.org/10.1016/j.leukres.2009.12.001
Status	Published - 2010

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Department of Translational Medicine (013017500), Clinical Microbiology, Malmö (013011000), Clinical Chemistry, Malmö (013016000), Emergency medicine/Medicine/Surgery (013240200), Host-Pathogen Interactions (013210032), Experimental cancer research (013017560), Faculty of Medicine (000022000)

Ämnesklassifikation (UKÄ)

Cancer och onkologi

FN:s Globala mål

Denna forskningsoutput relaterar till följande Globala mål

Tillgång till dokument

10.1016/j.leukres.2009.12.001

http://www.ncbi.nlm.nih.gov/pubmed/20053450?dopt=Abstract

1 Doktorsavhandling (sammanläggning)

Regulation of normal and cancer cells as a base for cell cycle-targeted therapy
Miftakhova, R., 2013, Department of Laboratory Medicine, Lund University. 194 s.
Forskningsoutput: Avhandling › Doktorsavhandling (sammanläggning)

Citera det här

@article{db7b67266d644ef984b8ef8b8f96e1fe,

title = "Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.",

author = "Regina Miftakhova and Tove Sandberg and Sharon Longno and Peter Bj{\"o}rk and Sven Bj{\"o}rnsson and Lazarevic, {Vladimir L J} and Jenny Persson and Anders Bredberg",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Department of Translational Medicine (013017500), Clinical Microbiology, Malm{\"o} (013011000), Clinical Chemistry, Malm{\"o} (013016000), Emergency medicine/Medicine/Surgery (013240200), Host-Pathogen Interactions (013210032), Experimental cancer research (013017560), Faculty of Medicine (000022000)",

year = "2010",

doi = "10.1016/j.leukres.2009.12.001",

language = "English",

volume = "34",

pages = "E145--E149",

journal = "Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis",

issn = "1873-5835",

publisher = "Elsevier",

}

TY - JOUR

T1 - Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.

AU - Miftakhova, Regina

AU - Sandberg, Tove

AU - Longno, Sharon

AU - Björk, Peter

AU - Björnsson, Sven

AU - Lazarevic, Vladimir L J

AU - Persson, Jenny

AU - Bredberg, Anders

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Department of Translational Medicine (013017500), Clinical Microbiology, Malmö (013011000), Clinical Chemistry, Malmö (013016000), Emergency medicine/Medicine/Surgery (013240200), Host-Pathogen Interactions (013210032), Experimental cancer research (013017560), Faculty of Medicine (000022000)

PY - 2010

Y1 - 2010

U2 - 10.1016/j.leukres.2009.12.001

DO - 10.1016/j.leukres.2009.12.001

M3 - Letter

C2 - 20053450

SN - 1873-5835

VL - 34

SP - E145-E149

JO - Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis

JF - Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis

ER -

Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.

Bibliografisk information

Ämnesklassifikation (UKÄ)

FN:s Globala mål

Tillgång till dokument

Forskningsoutput

Regulation of normal and cancer cells as a base for cell cycle-targeted therapy

Citera det här